Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn’s Disease: A Case Report
Herpes simplex virus (HSV) hepatitis is an uncommon cause of fulminant hepatic failure, seen mostly in immunocompromised patients. Conventional treatment modalities for inflammatory bowel disease (IBD), such as steroids and azathioprine, have been known to cause HSV hepatitis. However, the reported...
Main Authors: | Kanika Goel, Mark Bunker, Anna Balog, Jan F Silverman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.1177/1179547619858979 |
Similar Items
-
Disseminated Herpes Simplex Virus with Fulminant Hepatitis
by: Bassam H. Rimawi, et al.
Published: (2015-01-01) -
Fatal fulminant herpes simplex hepatitis secondary to tongue piercing in an immunocompetent adult: a case report
by: Lakhan Shaheen E, et al.
Published: (2008-11-01) -
Fulminant Hepatic Failure in a Patient with Crohn’s Disease on Infliximab Possibly Related to Reactivation of Herpes Simplex Virus 2 Infection
by: Gary Golds, et al.
Published: (2016-01-01) -
Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease
by: Jenny Roselli, et al.
Published: (2020-01-01) -
Fulminant hepatic failure secondary to herpes simplex virus type 2 infection in a renal allograft recipient
by: Amaravadi Ayyappa, et al.
Published: (2017-01-01)